News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Shiba Inu Price Prediction: SHIB Loses Channel Support as Burn Rate Falls 78% in Seven Days
CoinEdition·2026/05/19 07:57

Citadel Invests $1.7 Million in XRP ETFs as Institutional Interest Heats Up
Cryptonewsland·2026/05/19 07:42
How Capital Really Moves Into Crypto in 2026
BeInCrypto·2026/05/19 07:36
Goldman Sachs outlines hedging strategies amid AI trade momentum
Cryptobriefing·2026/05/19 07:31
British Pound stays on the back foot against Euro after mixed UK employment details
FXStreet·2026/05/19 07:21
Major XRP Breakout Brewing as Bollinger Bands Reach Extreme Compression
Cryptopotato·2026/05/19 07:21
Bitmine’s Ethereum Hoard Surges Past 5.28 Million ETH as Company Nears 5% Supply Target
Cryptopotato·2026/05/19 07:21

Bitcoin On The Line: Why This Weekly Close Is Critical For Its Rally
Newsbtc·2026/05/19 07:09

“Volatility Gap” Alert on the XRP Chart – What Does It Mean?
CryptoNewsNet·2026/05/19 07:06
Bnb forms major accumulation zone at $649 with 3rd signal
Cointurk·2026/05/19 07:06
Flash
02:11
OCBC Bank: The recent upside potential of Asian currencies is expected to be limited by the Federal Reserve's hawkish stance```htmlAccording to Golden Ten Data on June 18, strategists from OCBC Group Research said that, against the backdrop of the Federal Reserve maintaining a hawkish stance, the short-term upside for Asian currencies against the US dollar may be limited, especially for low-yielding currencies and those more sensitive to US Treasury movements, including the Thai baht, Korean won, and to some extent, the Singapore dollar. However, they added that falling oil prices remain a significant offsetting factor, easing current account and inflationary pressures for oil-importing currencies such as the Indian rupee, Philippine peso, and Indonesian rupiah.```
02:04
Biogen will acquire biotechnology company RayThera for $1 billion, targeting growth in the immunology sector.Golden Ten Data, June 18 — Biogen announced it has reached an agreement to acquire private biotechnology company RayThera for up to $1 billion, as the pharmaceutical company seeks to expand its immunology research and development pipeline. According to the statement, the deal will include an upfront payment to RayThera shareholders as well as additional milestone payments tied to clinical and regulatory progress. RayThera, headquartered in San Diego, has multiple anti-inflammatory drug candidates, with its lead project expected to enter phase I clinical trials in early Q3 2026. This deal comes amid a wave of biotechnology mergers and acquisitions, as major pharmaceutical giants invest heavily this year to expand their product pipelines.
02:04
SMBC Nikko Securities: If the Federal Reserve raises interest rates, it may increase the tightening pressure on the Bank of Japan(1) SMBC Nikko Securities strategist Ataru Okumura stated that if inflation prompts the Federal Reserve to raise interest rates, it could increase tightening pressure on the Bank of Japan. (2) Since the significant interest rate gap with the United States has long been a core driver of yen weakness, any new round of global tightening could expose the Bank of Japan's risk of being relatively slow to raise rates. (3) Although concerns about Japanese government intervention may prevent the USD/JPY from significantly exceeding 160, investors are skeptical about the sustainability of intervention measures, so the Bank of Japan may be forced to raise rates at a slightly faster pace.